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requirement for regularmonitoring of these resistant determinants
to execute the right antibiotics policy so as to reduce the irra-
tional use of expanded spectrum cephalosporins and to decrease
the antibiotic pressure and treatment failure in clinical setting in
this part of the world.
http://dx.doi.org/10.1016/j.ijid.2016.02.266
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Background: In this era of modern medicine, antimicrobial
resistance has emerged as a major health catastrophe. Emer-
gence of drug resistance mechanisms like Extended-spectrum
beta–lactamases (ESBLs), AmpCbeta-lactamases andmetallo-beta-
lactamases (MBLs) can be regarded as “biological quake” posing
therapeutic challenge to the health care settings. Therefore, this
study was designed to determine the prevalence of ESBL-, MBL-,
AmpC-producing bacteria in hospital-admitted patients.
Methods & Materials: A prospective study was conducted
among the inpatients of Medicare National Hospital in central
Kathmandu for four months (April-July, 2015), a period when the
hospital was engaged with “Nepal Earthquake 2015” victims too.
Different clinical specimens were collected, processed and the iso-
lates were identiﬁed following standard methodology. Antibiotic
sensitivity test was done by Kirby-Bauer disc diffusion method.
ESBL was detected by standard combination disc method. Besides,
tests for ESBL, AmpC, and co-production of ESBL and AmpC were
done by MASTDISCSTM ID AmpC and ESBL Detection Discs, as well
as ESBL and AmpC detection Ezy MICTM Strip (HiMedia, India).
EDTA-Imipenem combination disc method was followed for MBL
detection.
Results: Among the total 75 gram-negative bacterial isolates
resistant to third generation cephalosporin, ESBLwas seen in 30.6%
(n=23). Similarly, MBL and AmpC production were seen in 8%
(n=6) and 1.3% (n=1) respectively. Interestingly, ESBL-AmpC co-
production was found in 4% (n=3). Escherichia coli was the most
frequent ESBL-producer (n=20). E. coli was found to produce MBL
(n=4), AmpC (n=1), and ESBL-AmpC combination (n=2) as well.
Two isolates of P. aeruginosa were ESBL-AmpC co-producers. Out
of 23 ESBL-producer, 78.2% (n=18) were from intensive care unit
patients. The ESBL-producing bacteria showed sensitivity to dif-
ferent antibiotics as follows- meropenem (n=21, 91.3%), amikacin
(n=20, 86.9%), and cefoperazone-sulbactam (n=19, 82.6%). Con-
sistent results were found with different methods employed for
detection of ESBL and AmpC.
Conclusion: ESBL-producing bacteria were more commonly
seen though AmpC- and MBL-producers were relatively less
frequent. Special strategy like antibiotic stewardship should be fol-
lowed in our setting before the situation turns out to be havoc.
Identiﬁcation, characterization and surveillance of antibiotic sus-
ceptibility proﬁle of beta-lactamase-producing organisms can lead
to successful infection control.
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Background: Carbapenem resistant Enterobacteriaceae (CRE)
have emerged and disseminated widely causing a variety of infec-
tions. The emergence of carbapenem resistant Enterobacteriaceae is
associated with limited therapeutic options and increased mortal-
ity in patients infected by these strains. These organisms also have
the propensity to undergo widespread dissemination via mobile
genetic elements. Enteric strains possessing these carbapenemases
have shownremarkable success in the formof large scale geograph-
ical dissemination. Gut colonization by CRE may act as reservoir of
these pathogens for dissemination within an enclosed setting as
in a hospital. To the best of our knowledge, there are no studies
of CRE fecal carriage using genotypic methods and those analysing
risk factors leading to such colonization in hospitalised patients in
India.
Methods & Materials: We conducted the present study to
observe gut carriage rate of CRE in patients presenting to our ter-
tiary carehospital usingbothphenotypic (modiﬁedHodge test) and
genotypic (polymerase chain reaction for blaVIM, blaKPC,blaIMP and
blaNDM-1 genes) methods and tried to identify the risk factors for
CRE gut colonization.
Results: A total of 239 fecal swabs yielded 259 Enterobacteri-
aceae isolates, of which 108 isolates (majority included E. coli and
Klebsiella spp.) from 84 patients showed presence of CRE (preva-
lence 84/239; 35.14%); 28 isolates from 23 patients had blaNDM-1
while 20 isolates from17patients possessed blaVIM gene. No isolate
was positive for blaKPC and blaIMP genes. Although highest isolation
of CREwas from thewards, approximately half of patients of inten-
sive care units yielded CRE in fecal swabs. The CRE were also found
to have signiﬁcantly high antimicrobial resistance as compared to
non-CRE isolates.Multivariate analysis of risk factors showeduse of
any antibiotic (P =0.002), cephalosporins use (P =0.000) and pres-
enceof any indwellingdevice (P =0.014) as independent risk factors
for acquiring gut colonization.
Conclusion: The study is the ﬁrst from India to show high CRE
carriage in patients admitted to a tertiary care centre and empha-
sises the need of strict antimicrobial stewardship implementation
in hospitals to prevent dissemination of multidrug resistant CRE.
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